SE435898B - Sett att framstella prostaglandin e-kompositioner - Google Patents

Sett att framstella prostaglandin e-kompositioner

Info

Publication number
SE435898B
SE435898B SE7805499A SE7805499A SE435898B SE 435898 B SE435898 B SE 435898B SE 7805499 A SE7805499 A SE 7805499A SE 7805499 A SE7805499 A SE 7805499A SE 435898 B SE435898 B SE 435898B
Authority
SE
Sweden
Prior art keywords
glycol
monoester
prostaglandin
alkylene glycol
alkylene
Prior art date
Application number
SE7805499A
Other languages
English (en)
Swedish (sv)
Other versions
SE7805499L (sv
Inventor
K Tsukada
S Tanaka
S Kobayashi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of SE7805499L publication Critical patent/SE7805499L/xx
Publication of SE435898B publication Critical patent/SE435898B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7805499A 1977-05-12 1978-05-12 Sett att framstella prostaglandin e-kompositioner SE435898B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52054679A JPS6019734B2 (ja) 1977-05-12 1977-05-12 安定なプロスタグランジンｅ類製剤の製法

Publications (2)

Publication Number Publication Date
SE7805499L SE7805499L (sv) 1978-11-13
SE435898B true SE435898B (sv) 1984-10-29

Family

ID=12977466

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7805499A SE435898B (sv) 1977-05-12 1978-05-12 Sett att framstella prostaglandin e-kompositioner

Country Status (7)

Country Link
JP (1) JPS6019734B2 (da)
CA (1) CA1090255A (da)
CH (1) CH635513A5 (da)
DK (1) DK210778A (da)
ES (1) ES469822A1 (da)
NL (1) NL7805180A (da)
SE (1) SE435898B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
US4409239A (en) * 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
DE19541815B4 (de) * 1995-11-09 2008-04-10 Bannert, Christian, Dr. Verwendung einer Lösung von Polyethylenglykol in Wasser als wässrige Spüllösung zur Prävention oder Behandlung von zähem Schleim, der in Verbindung mit Strahlen- oder/und Chemotherapie-induzierten Erkrankungen der Schleimhäute auftritt
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil

Also Published As

Publication number Publication date
NL7805180A (nl) 1978-11-14
ES469822A1 (es) 1978-12-16
CH635513A5 (en) 1983-04-15
JPS6019734B2 (ja) 1985-05-17
CA1090255A (en) 1980-11-25
SE7805499L (sv) 1978-11-13
DK210778A (da) 1978-11-13
JPS53139716A (en) 1978-12-06

Similar Documents

Publication Publication Date Title
SE504220C2 (sv) Aminsalter för framställning av klavulansyra
SE435898B (sv) Sett att framstella prostaglandin e-kompositioner
DE1695711A1 (de) Verfahren zur Herstellung von N-Benzoyl-3-indolylfettsaeuren
US2928875A (en) Isopropylhydrazine derivatives
DE1153745B (de) Verfahren zur Herstellung von 4-Halogen-3-sulfamoylbenzoesaeureestern
US2933514A (en) New derivatives of testosterone
US2759828A (en) Stabilization of fats and oils with-co-r derivatives of 1, 2, 4-trihydroxybenzene and preparation of related compounds
Callow The purification of ergosterol
DE1793693C3 (da)
DD202434A5 (de) Verfahren zur herstellung von 2,3,4-trinor-1,5-inter-m-phenylen-prostacyclin-derivaten
DE1643965A1 (de) Neue Karbamid-Derivate und Verfahren zu ihrer Herstellung
DE2156501A1 (de) Verfahren zur herstellung von 5,6gamma-pyridonderivaten
US3969383A (en) Fat compositions stabilized with esters of fatty acids and tertiary lower alkyl substituted hydroquinones and method therefrom
US2794036A (en) Cortisone-undecylate
US3346580A (en) Lysergic acid amides
AT303707B (de) Verfahren zur Herstellung von neuen 1-sek.Amino-2-hydroxy-3-[(p-alkenyloxy- oder p-alkinyloxy)-phenoxy]-propanen und ihren Säureadditionssalzen
DE2645692C2 (de) Thiazolidin-4-carbonitrile
GB1470012A (en) Ketone peroxide composition
US3051733A (en) Di-17alpha(delta4-androsten-17beta-ol-3-one) butadiyne
US3202685A (en) 3, 3'-steroid azines
US2734056A (en) Chsoco
DE2356690A1 (de) Pyrazol eckige klammer auf 3,4-d eckige klammer zu -pyrimidin-n-oxide, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US2006166A (en) Lacquer solvent
US3081318A (en) 4-androstene-2alpha, 3, 17beta-triols and preparation thereof
AT228804B (de) Verfahren zur Herstellung von Thionothiolphosphorsäureestern

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7805499-6

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7805499-6

Format of ref document f/p: F